How to turn an old electronic toy into a carbon-ceramic electronic cigarette

A group of researchers from the University of Toronto and ETH Zurich have invented an electronic cigarette powered by an entirely new chemical compound that makes the vapour a lot more attractive to the human nose.

They say their invention is a key step towards creating a device that will be more appealing to people with asthma, who often suffer from a lack of breathable air.

The researchers say the new material, which they have dubbed oxygen valences, works by changing the electron state of an atom that has been attached to a carbon atom.

The electrons are now attached to another atom, which is not the original atom.

The new compound was discovered in 2013, and was described in the journal Nature.

The team is now working to develop a method to turn the compound into an electrode that can be attached to electronic toys, making it easier to use.

The team is developing the device with support from the Ontario Institute for Innovation Research.

The research is part of a broader push to develop technologies to help people with respiratory problems control their airways and improve their quality of life.

The Ontario Lung Association estimates that a third of people in Ontario have asthma and that more than half of the country’s population is affected.

In an interview with CBC News, Professor Mark Gomes said the chemical could help reduce or eliminate the need for regular inhalation masks and help people who suffer from asthma, like those who suffer allergies.

“We want to give people breathing space to breathe without having to use masks or masks and goggles,” he said.

“If you are an adult who is suffering from asthma you want to be able to breathe and you want a device to help you do that.”

In a way it could be a way to replace the respirator.

“The team has been working to find a way of making oxygen derivatives with a low toxicity and a wide range of different applications.

It could be used in electronics, medical devices, medical implants, and even as a medical inhaler.

The group is hoping to get the compound to market in 2019.